France· FR:62104529
KAFTRIO 60 mg/40 mg/80 mg, granulés en sachet
A medicinal product containing élexacaftor + tezacaftor + ivacaftor, registered in France by VERTEX PHARMACEUTICALS (IRELAND), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉLEXACAFTOR + TEZACAFTOR + IVACAFTOR
- Manufacturer
- VERTEX PHARMACEUTICALS (IRELAND)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093028034828 (4 x7) sachet(s) BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminiumEUR 8.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Élexacaftor + tezacaftor + ivacaftor in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenKaftrio 37,5 mg/25 mg/50 mg Filmdragerad tablettVertex Pharmaceuticals Ireland Ltd
- SwitzerlandTrikafta 100 mg / 50 mg / 75 mg, 150 mg, FilmtablettenVertex Pharmaceuticals (CH) GmbH
- CzechiaKAFTRIOVertex Pharmaceuticals (Ireland) Limited, Dublin
- SpainKAFTRIO 37,5 MG/25 MG/50 MG COMPRIMIDOS RECUBIERTOS CON PELICULAVertex Pharmaceuticals (Ireland) Limited
- FinlandKaftrioVertex Pharmaceuticals (Europe) Limited
- CanadaTRIKAFTAVERTEX PHARMACEUTICALS (CANADA) INCORPORATED
- United KingdomKaftrio 37.5mg/25mg/50mg tabletsVertex Pharmaceuticals (Europe) Ltd
- IrelandKaftrio 37.5 mg/25 mg/50 mg film-coated tabletsVertex Pharmaceuticals (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kaftrio
- Liechtenstein · Kaftrio
- Norway · Kaftrio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb20b4ae-1cfc-4689-9271-e6b08ef93b97 GET /v1/drugs/cb20b4ae-1cfc-4689-9271-e6b08ef93b97?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62104529",
"date_amm": "2023-11-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1468",
"substance": "ÉLEXACAFTOR + TEZACAFTOR + IVACAFTOR",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "granulés",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about élexacaftor + tezacaftor + ivacaftor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.